ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $242,000 | +17.5% | 8,635 | +9.0% | 0.00% | 0.0% |
| Q4 2020 | $206,000 | -29.9% | 7,920 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $294,000 | -58.4% | 7,920 | -42.5% | 0.00% | -50.0% |
| Q2 2020 | $707,000 | +42.0% | 13,770 | -12.8% | 0.00% | 0.0% |
| Q1 2020 | $498,000 | -34.0% | 15,792 | +24.7% | 0.00% | 0.0% |
| Q4 2019 | $755,000 | +65.2% | 12,661 | +1.6% | 0.00% | 0.0% |
| Q3 2019 | $457,000 | -22.3% | 12,461 | -1.4% | 0.00% | 0.0% |
| Q2 2019 | $588,000 | +14.2% | 12,634 | -1.5% | 0.00% | 0.0% |
| Q1 2019 | $515,000 | -16.0% | 12,830 | -3.7% | 0.00% | -33.3% |
| Q4 2018 | $613,000 | +118.9% | 13,320 | +244.2% | 0.00% | +50.0% |
| Q1 2018 | $280,000 | +26.1% | 3,870 | +15.0% | 0.00% | +100.0% |
| Q4 2017 | $222,000 | – | 3,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |